相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
Barry W. Neun et al.
MOLECULES (2020)
Detection of Endotoxin in Nano-formulations Using Limulus Amoebocyte Lysate (LAL) Assays
Barry W. Neun et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities
Swamy Kumar Polumuri et al.
SCIENTIFIC REPORTS (2018)
Distinct in vitro Complement Activation by Various Intravenous Iron Preparations
Julia Cordelia Hempel et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity
Lydia A. Haile et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model
Joshua A. Jackman et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
Marina A. Dobrovolskaia
JOURNAL OF CONTROLLED RELEASE (2015)
Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins
Lydia Asrat Haile et al.
PLOS ONE (2015)
Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release
Claudia Weber et al.
TOXICOLOGY REPORTS (2015)
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Vibha Jawa et al.
CLINICAL IMMUNOLOGY (2013)
Scientific considerations in the review and approval of generic enoxaparin in the United States
Sau Lee et al.
NATURE BIOTECHNOLOGY (2013)
Taking immunogenicity assessment of therapeutic proteins to the next level
I. C. Buettel et al.
BIOLOGICALS (2011)
Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages
Alexandre Esteban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Meeting report on protein particles and immunogenicity of therapeutic proteins: Filling in the gaps in risk evaluation and mitigation
John Carpenter et al.
BIOLOGICALS (2010)
Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins
Daniela Verthelyi et al.
PLOS ONE (2010)
TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity
Jun Du et al.
VACCINE (2010)
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Trine H. Mogensen
CLINICAL MICROBIOLOGY REVIEWS (2009)
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
Jinhai Wang et al.
NATURE BIOTECHNOLOGY (2008)
Immunogenicity of biopharmaceuticals
Michele Kessler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Scientific and regulatory considerations on the immunogenicity of biologics
Gopi Shankar et al.
TRENDS IN BIOTECHNOLOGY (2006)
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
J Szebeni
TOXICOLOGY (2005)
Meconium is a potent activator of complement in human serum and in piglets
A Castellheim et al.
PEDIATRIC RESEARCH (2004)
Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells
TM Schaefer et al.
IMMUNOLOGY (2004)
Toll receptors, CD14, and macrophage activation and deactivation by LPS
MA Dobrovolskaia et al.
MICROBES AND INFECTION (2002)
Antigenicity and immunogenicity of synthetic peptides
MHV Van Regenmortel
BIOLOGICALS (2001)
Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions
J Szebeni et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
分享论文
